All Posts

Welcome to the latest update from the Ministry of Health | Manatū Hauora on the regulation of medicines, medical devices and natural health products.   This newsletter includes updates on the following:  Important policy decisions on the Medical Products Bill   Community pharmacy ownership  Advertising   Statutory timeframes  Offences and penalties  Medical products regulator  Medical products exports  Supporting innovation under the Medical Products Bill  Natural health prod

Medicinal cannabis products that meet the minimum quality standard The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the Regulations) set the minimum quality standard that medicinal cannabis products and ingredients must meet before they can be supplied in New Zealand. Importers, manufacturers, and suppliers must apply for assessment and provide evidence to the Medicinal Cannabis Agency to verify that their products meet the minimum quality standard. Helius NZ Maya T

Coming up in CPD: Goodfellow Symposium 2026 21/22 March 2026: Curated specifically for Primary Care:  Check it out here . Breast health in midlife: Risk assessment & cancer detection WEBINAR 21 October: Magdalena Biggar, Carla Pajak and Sugania Reddy in this comprehensive session on midlife breast health. Register here Back to basics: Sun, sunscreen, skin cancer prevention WEBINAR 28 October: Dr Sam Mayhew, GP Specialist and Skin Cancer Doctor, on skin cancer prevention. Regi

We are writing to inform you that Pharmac is expecting a constrained supply of oxytocin injection 10 IU per mL, 1 mL ampoule (Pharmacode:...

Kia ora koutou Child Poverty Reduction Minister Louise Upston has announced that the Government has accepted all 14 of the recommendations made by the review by Dame Karen Poutasi in 2022. The Government response is focused on strengthening the children’s system, and improving safeguards, to protect against and better respond to child harm.   Child and youth ministers will oversee implementation of the integrated government response and drive work at pace to deliver on all 14

Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week...

Candesartan cilexetil (Candestar) Tab 32 mg  (Pharmacode: 2380439) Due to delays at the factory, the supplier is out of stock of this...

This link  will take you to the proposal to enter into an agreement with Obex Medical Limited (“Obex”) for medical devices in the...

From the 1 November 2025, Pharmac will be widening access to ticagrelor, a blood-thinning medicine that helps prevent blood clots, for...

Medicinal cannabis products that meet the minimum quality standard The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the...

Discontinuation:   We are writing to inform you that Sanofi is discontinuing supply of ketoprofen (Oruvail) SR Capsules 200mg.    Key...

There is a (currently free) clinical information AI tool called Open Evidence 1 . It has been developed by the New England Journal of...

Pharmac Decision: Changes to support increased prescription lengths  Please follow this link  to the Pharmac decision regarding changes...

New community medicine notices Chloramphenicol eye drops: Chlorsig is changing to Chlorafast  (Pharmacode: 335142) Chlorsig eye drops are...

Proposal to change funding criteria and supply arrangements for antiretroviral medicines used to treat HIV Pharmac is now consulting...

Coming up in CPD: Unlocking Options: Insulin Use in Type 2 Diabetes Management WEBINAR 14 October: Ryan Paul on the current role of...

Issue 330 - 2 October 2025 Welcome to the fortnightly Health Improvement and Innovation Digest. The Digest has links to key evidence of...

Proposal to change funding criteria and supply arrangements for antiretroviral medicines used to treat HIV Pharmac is now consulting...

We are writing to inform you of that there has been a delay with a recent shipment of Condyline solution 0.5%   Key messages: AFT...